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Abstract

In an attempt to isolate and identify proteins that differentially interact with or locate near
lamin A and progerin, we used a previously described method named BioID (proximitydependent biotin identification). This method is based on fusion of a promiscuous E. coli biotinprotein ligase (BL) to a targeting protein (in this study, lamin A-GFP and progerin-GFP). The
biotin ligase biotinylates amino residues in proteins that are near-neighbors of the fusion protein.
To create the fusion proteins, BL was sub-cloned from a pcDNA3.1 MCS-BirA(R118G)-HA
plasmid donated by Kyle Roux from University of South Dakota. The BL fragment was ligated
into a pNEBR-X1-lamin A-GFP and pNEBR-X1-progerin-GFP which inducibly express the
fusion proteins in mammalian cells, under control of pNEBR-R1 Rheoswitch regulator plasmid.
Two stable cell lines expressing the GFP-BL-lamin A and GFP-BL-progerin chimeras
were created. The expression of the chimeras was induced by incubation with 500nM of
GenoStat for 24 hours in the presence of 50mM Biotin. Biotinylated proteins were isolated from
cell lysates by incubation with streptavidin magnetic beads. Proteins were separated by SDSPAGE and sent for identification by mass spectrometry. In conclusion, we isolated multiple
proteins that differentially associate with and/or are proximate to lamin A and progerin in vivo.
The identification of such proteins may shed light into the mechanism by which progerin causes
its deleterious effects. The purpose of this research is to attempt to identify the neighboring
proteins that differentially interact with or locate near lamin A and progerin.
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Chapter 1: INTRODUCTION
Proteins are vital and necessary for the continuation of human life, yet not enough is
known about their interaction with other proteins or protein networks. It has gradually become
more obvious that proteins can only be fully understood in the context of protein-protein
interactions. These networks of interactions also are fundamental in understanding disease
processes1, such as Hutchinson-Gilford Progeria Syndrome. "BioID", a new approach to
understand these interactions, was recently developed as an alternative to previous screening
processes for protein-protein interactions2. Previous methods to identify protein-protein
interactions have helped scientists understand more about these interactions, but there are
significant drawbacks. The most common techniques for protein-protein interaction screening
have been affinity capture screening and yeast two-hybrid systems; each has its positive and
negative aspects.
Yeast two-hybrid systems are used to screen for protein-protein interactions3 and proteinDNA interactions4 by testing for physical interactions between two proteins or a protein and
DNA molecule3,4. In most eukaryotic cell transcription factors, the activating and binding sites
can function in close proximity with each other without physical binding5. In the yeast twohybrid assay, a genetically modified yeast (lacking in certain vital nutrients) is infused with two
separate bait and prey plasmids6. The bait protein's coding sequence is fused with the DNA
binding domain (BD). The prey protein is fused into the transcription activation domain (AD).
These vectors are then transfected into a yeast strain. If the "bait" and "prey" proteins interact,
transcription of the gene LacZ occurs and a change in cell phenotype indicates success3.
The yeast two-hybrid system is helpful and very effective when results are achieved,
however, some studies have shown that this system can give up to 70% false
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positives/negatives7. These false readings can be caused by many reasons. The most important
reason is that all interactions take place in vitro2. While in vitro, the two-hybrid system only
takes place in the nucleus; therefore, proteins that interact outside the nucleus (but not in the
nucleus) may be read as negative7. Also, assay variants over-express fusion proteins which lead
to false positives7.
Another method called affinity capture screening may be used to purify an enzyme
solution or identify compounds that bind to a particular substance8. It usually involves a cell
lysate solution being passed through a gel to separate out molecules in the solution. The gel is
commonly made of agarose. This method is effective when successful, but has disadvantages.
High-throughput genetic approaches take place in vitro, usually not having the proper machinery
for post-translational modifications to binding partners; this can lead to incomplete data2.
A new approach was recently developed as an alternative to the previous stated screening
processes for protein-protein interactions. Called "BioID", it is a groundbreaking method to
screen for proteins in a natural cellular environment (in vivo) 2. The main goal of the BioID
method is to identify vicinal proteins by proximity-dependent biotinylation (marking of proteins
with biotin) 2. It was developed by Drs. Roux, Kim, Raida, and Burk at the University of South
Dakota. In the development of the BioID method, these researchers used protein lamin A and
“biotin ligase” BirA*.
Lamin A is an intermediate filament protein that is encoded by the LMNA gene9. This
protein is found in the nuclear lamina. Lamin A is highly insoluble and has been proven difficult
to define via conventional approaches9; therefore, is an ideal candidate for BioID2. BirA is a
DNA-binding biotin:protein ligase in Escherichia coli that regulates the biotinylation of a
subunit of acetyl-CoA carboxylase and represses transcription for the biotin biosynthetic
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operon10. However, BirA is too selective to use in BioID2.BirA*, also known as R118G, is a
mutant of BirA. It biotinylates proteins more promiscuously than BirA2.
In BioID, a biotin ligase is fused to a protein of interest; in Dr. Roux’s experiment with
his colleagues, they fused BirA* to lamin A2. The biotin ligase is then introduced into a live
mammalian cell (Roux used HeLa cells) where it biotinylates (marks with biotin) vicinal proteins
once the culture medium has biotin. These
biotinylated proteins are then selectively
isolated and identified2. Mass spectrometry
is used to identify the biotinylated proteins2.
BioID was used by Dr. Roux and his
colleagues in this fashion to successfully
biotinylate many known vicinal proteins in
the nuclear envelope2 of HeLa cells and
identified a novel protein, SLAP752.

Figure 1. BioID Method. Adapted from Roux et al. (2012)

BioID was proven by Roux to be effective at biotinylating vicinal proteins. It has
advantages over other common protein-protein interaction screening methods because it takes
place in vivo. However, BioID has its weaknesses as well. It relies on the excess of biotin to be
added to a culture in order to advance biotinylation. In theory, this can cause false positives or an
inflated amount of biotinylated proteins2; however, that did not occur in Roux’s experiment.
Also, current studies have only been in mammalian cells so it cannot be said whether or not
BioID is useful in all types of cells.
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BioID is a new approach that is powerful and effective. It is broadly accessible and can
be used by a wide range of researchers2. However, it should be used as a complement to the
current conventional methods. The method is innovative and can be used to help elucidate the
protein-protein interactions in laminopathies such as Hutchinson-Gilford Progeria Syndrome.
Mutations in the LMNA gene, which encodes the nuclear filament protein lamin A, cause
the premature aging disease Hutchinson-Gilford Progeria Syndrome. One of these mutations
results in the expression of a mutant lamin A, with a 50-aa in-frame deletion within its C
terminus. Our laboratory previously demonstrated that this deletion leads to a stable
farnesylation and carboxymethylation of the mutant lamin A. These modifications cause an
abnormal association of progerin during mitosis, induce changes in the cell cycle progression,
and may cause DNA damage (among many other effects).
We employed a recently developed technique, BioID, to identify vicinal proteins by
proximity-dependent biotinylation. This in vivo technique has an advantage over previous
screening methods such as affinity capture screening and yeast two-hybrid systems due to its
ability to allow proteins to interact in a natural cellular environment. We use BioID to
experiment with lamin A∆50 (progerin) to understand its interactions in the hope of learning to
regulate it and cure laminopathies such as Progeria.
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Chapter 2. MATERIALS AND METHODS

Antibodies: Mouse anti-GFP was from ABCAM (Cambridge, MA) rabbit anti-biotin ligase was
from Hoelzel-Biotech (Germany). Secondary antibodies conjugated to Alexa-488, Alexa-565, or
Horse radish peroxidase were from Invitrogen. Dynabeads® MyOne™ Streptavidin C1 biotin
binding beads were also from Invitrogen.
Plasmids: pcDNA3.1 MCS-BirA* plasmid encoding a bacterial biotin ligase (BL) was donated
by Kyle Roux from University of South Dakota. pNEBR-X1-lamin A-GFP and pNEBR-X1progerin-GFP were created by Christina Bridges in Dr. Rusiñol Lab.
Creation of biotin ligase fusion constructs: Biotin ligase/lamins fusion constructs were created
by sub-cloning the biotin ligase open reading frame from pcDNA3.1 MCS-BirA* into either
pNEBR-X1-lamin A-GFP and pNEBR-X1-progerin-GFP. Briefly, a biotin ligase fragment
containing ectopic restriction enzymes sites for Not I and BamH I were generated by Polymerase
Chain Reaction (PCR) using the following primers:
5’-GGAGAAATCTCCCTGAGAAGCGCAGAGAAGGGCGGCCGC-3’
5’-GGATCCCCCAAGCTGGCTAGCCACCATGGAACAAAAACTCATCTC-3’. For the
restriction enzyme digestion reaction, a combination of 1µL 10x buffer, 6.5µL H20, 2µL DNA,
and 0.5µL enzyme were combined in a microfuge tube in order. This mixture was incubated for
1 hour at 37 ˚C.
The biotin ligase fragment was ligated in frame after GFP into a pNEBR-X1-lamin AGFP and pNEBR-X1-progerin-GFP. A Takara ligation kit was used and reaction was carried out
for 12 h at 16˚C. E. coli cells were transformed with the products of the ligation reaction and
plated on LB-agar plates containing 100µg/ml ampicillin. Colonies were picked after a 14 hour
incubation at 30 ˚C. Cells from colonies were grown in 6 mL of LB media containing 100µg/mL
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ampicillin for 12 hours at 30 ˚C. Plasmids were purified from these or larger (500 mL) cultures
using Qiagen plasmid purification kits according to manufacturer protocol. Constructs were
confirmed by DNA sequencing at the Quillen College of Medicine Core Facility.
Cell lines: To express the biotin ligase/lamin fusion proteins, we chose the Rheoswitch®
inducible protein expression system from New England Biolabs. The RheoSwitch® Mammalian
system allows for inducible gene expression achieved through the highly specific interaction of a
synthetic inducer, RheoSwitch Ligand RSL1 (GenoStat, from Millipore), and a nuclear
receptor/transcription factor. These factors are activated in the presence of GenoStat, and the
level of gene transcription can be regulated by adjusting the concentration of GenoStat in the
culture media.
Creation of stable Rheoswitch® cell lines expressing GFP-BL-lamin A and GFP-BLprogerin: pNEBR-X1-lamin A-BL-GFP and pNEBR-X1-progerin-BL-GFP plasmids were
transfected into Rheoswitch T3T cells by using TransIT-3T3™ from Mirus Bio (Madison WI) or
MegaTran 1.0™ from Origene (Rockville MD) in growth medium (DMEM, 10% heat
inactivated bovine calf serum, Penicillin/Streptomycin) according to manufacturer protocol.
After 24 hours, cells were trypsinized, diluted in a ration 1:10 and incubated in growth medium
with 800ug/mL G418 and 200ug/mL Hygromycin for two weeks, changing medium every 3-4
days. Colonies of resistant cells were selected, isolated, expanded, induced with GenoStat and
checked for expression by fluorescence microscopy. Clones with various levels of expression
were obtained and stored on liquid nitrogen.
Inducible expression of biotin ligase-lamin fusion proteins: 107 cells were plated in 10 cm
culture dishes and incubated in the presence of various concentrations of GenoStat for 48 hours.
Cells were then washed twice with 5 mL of PBS and scraped in 1 mL of the ice-cold lysis buffer
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(50 mM Tris, pH 7.4 250 mM NaCl 5 mM EDTA 50 mM NaF 1 mM Na3VO4 1% Nonidet P40
(NP40) 0.02% NaN3) containing Halt™ (protease and phosphatase inhibitors cocktail from
Pierce). Cells lysates were kept on ice for 10 minutes and then frozen at -80 ˚C.
Immunoblotting: Lysates were next subjected to SDS-PAGE using the Novex electrophoresis
system from Invitrogen according to manufacturer protocol. A constant 200 volts was used for
approximately 45 minutes to perform the electrophoresis. Pre-stained molecular weight markers
were ran alongside the samples. Proteins were then transferred to PVDF membranes using a
semi-dry electro blotter, iBlot® from Invitrogen/Life Technologies. Manufacturer protocol was
followed and the transfer time was set to seven minutes. Western Blotting with anti-GFP or antibiotin ligase was performed following standard procedure using primary antibodies at a dilution
of 1:10,000 and secondary antibodies at a dilution of 1:25,000.
Sub-cellular localization of biotin ligase-lamin fusion proteins by immunofluorescence
3T3 Rheoswitch cells were plated on coverslips and incubated with GenoStat for 24 hours. Next,
cells were rinsed with 1x PBS prior to fixing by incubation with 4% formaldehyde PBS for 15
minutes at room temperature. Cells underwent three PBS washes, and were then permeabilized
with 0.2% Triton X-100 in PBS for five minutes on ice, washed, and blocked with 10% BSA in
PBS for five minutes on ice. Cells were incubated with primary antibody for one hour at room
temperature, washed and incubated with a secondary antibody for one hour. Dilution for mouse
anti-GFP was 1:500 and for rabbit anti-biotin ligase 1:250 in blocking reagent. Dilution for the
Alexa488 and Alexa565 secondary antibodies was 1:5000. Following the second incubation,
cells were washed three times with PBS then treated with DAPI-containing anti-fade mounting
medium to seal the stained cells between the coverslip and a microscope slide. Images were
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obtained using an EVOS-fl automatic microscope from AMG (Life Technologies). All image
processing (contrast stretching and image overlays) was done by the microscope software.
BioID experimental protocol: The BioID protocol was followed as previously described by
Roux2 in order to identify proteins interacting with lamin A and progerin.

Figure 4. BioID experimental protocol. Adapted from Roux et al. (2012)

Fusion protein expression was induced by incubation with 500nM of Genostat for 24 hours in the
presence of 50µM Biotin to stimulate biotinylation of vicinal proteins. The cells were lysed in
SDS-containing buffer to solubilize all biotinylated proteins. The biotinylated proteins were then
recovered with Dynabeads® MyOne™ Streptavidin C1 beads according to manufacturer
protocol. Briefly, Lysates were incubated with the beads for 30 min at room temperature using
gentle rotation. After separation with a magnet for 2–3 min, the coated beads were washed 4–5
times in PBS containing 0.1% BSA and resuspended in 50 to 100 µl. Immobilized biotinylated
proteins were released by incubation for 5 min at 90°C in nonionic water or 0.1% SDS. Samples
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were subjected to Sodium dodecyl sulfate polyacrylamide gel electrophoresis SDS-PAGE and
protein containing lanes were cut into 5 mm pieces and send AB Sciex (Framingham, CT) for
identification by MALDI-TOF mass spectrometry.
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Chapter 3: RESULTS
Creation of biotin ligase-lamin fusion constructs
Biotin ligase-lamin constructs were successfully created.
Creation of stable cell lines expressing biotin ligase-lamins fusion proteins
Two stable 3T3 Rheoswitch cell lines were created, one containing the GFP-BL-lamin A
chimera and another cell line containing the GFP-BL-progerin chimera.
Inducible expression of biotin ligase-lamin fusion proteins
To ensure that the newly created cell lines contained the inducible protein chimeras, Western
Blotting was used with various levels of
Figure 5. Protein expression in Western Blot

GenoStat (0 nM, 250 nM, 500 nM). The
experimental controls without the biotin
ligase were in 100 nM of GenoStat. As
expected, the fusion proteins were
expressed in the cells with the biotin ligase
BirA* proportionally with increasing levels of GenoStat. The fusion proteins were not expressed
in the control cell groups.
Sub-cellular localization of biotin ligase-lamin fusion proteins
Immunofluorescence of 3T3 Rheoswitch
BL-GFP-LA cells and 3T3 Rheoswitch BLGFP-LA∆50 cells showed the sub-cellular
localization of biotin ligase-lamin fusion
proteins. In the 3T3 Rheoswitch BL-GFPFigure 6. Immunofluorescence of cells
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LA, the fusion proteins were in the expected location of the nuclear lamina and nucleoplasma of
the cell. In the 3T3 Rheoswitch BL-GFP-LA∆50 cells, the biotin ligase-lamin fusion proteins
were not in the nuclear lamina but rather in aggregates inside the nucleus and perhaps the
cytoplasm or endoplasmic reticulum membranes.
BioID experimental protocol
Proteins biotinylated by biotin ligase in 3T3 Rheoswitch cells expressing BL-GFP-LA and BLGFP-LA∆50 were identified by mass spectrometry. Most of the identified proteins are known.
There were proteins that
were differentially
biotinylated by BL-GFPLA or BL-GFP-LA∆50.
Examples of these
biotinylated proteins and
their main functions are
seen in Figure 7.
Figure 7. Examples of proteins differentially biotinylated by 3T3
RheoswitchBL-GFP-LA or 3T3 RheoswitchBL-GFP-LA∆50
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Chapter 4: DISCUSSION AND CONCLUSION
During this study, BioID and other techniques were used to identify neighboring proteins
that differentially interact with or locate near lmin A and progerin. First, two new cell lines were
successfully created with a biotin ligase BirA*: a 3T3 Rheoswitch BL-GFP-LA cell line and a
3T3 Rheoswitch BL-GFP-LA∆50 cell line. This was done by transfecting lamin A-Biotin
Ligase-Green Fluorescence protein constructs and ∆50Lamin A-Biotin Ligase-Green
Fluorescence Protein constructs into 3T3 Rheoswitch cells. To ensure the inducible system
functioned properly, the new cell lines were induced with GenoStat and the protein expression
levels were compared to control cells. Immunofluorescence was also used to ensure proper
location of the expressed proteins.
Once these cell lines were created, the BioID method was implemented to isolate vicinal
proteins to lamin A and progerin. The BioID method consisted of the inducible expression of the
biotin ligase fusion protein in 3T3 Rheoswitch cells, biotinylation of vicinal proteins, lysis of
cells in SDS-containing buffer, recovery of biotinylated proteins on stravidin-conjugated beads,
and identification via mass spectrometry. The technique was successful in isolating and
identifying proteins known to interact in vivo with lamin A and progerin. It was seen that most of
these interacting proteins are known. It was also determined that there are proteins that interact
with either lamin A or progerin, but not both.
Certain interesting interactions were seen that may help understand laminopathies and
similar disease processes. For example, progerin was found to interact with a protein of the
endoplasmic reticulum, Sec61α1; this could mean that progerin leaves the nuclear lamina and
interacts with the walls of the endoplasmic reticulum. Also, Zmpste24, a crucial protein involved
in the maturation of lamin A, does not interact with progerin. It is important to continue studying
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similar protein interactions unique to progerin and lamin A in order to learn why some protein
dysfunctions occur. To shed more light on these processes, further studies can include
synchronized cells in differing phases of the cell cycle such as G0, G1, S, etc. Also, further
exploration of the protein interactions can be accomplished through fluorescence resonance
energy transfer (FRET), co-immunoprecipitation (Co-IP), or site directed mutagenesis.
In conclusion, this study is a proof of concept for identifying the neighboring proteins
that differentially interact with or locate near lamin A and progerin. This study’s successful
identification of near-neighbors of laminar proteins in vivo is a step on the path to completely
understanding laminopathies and disease processes dealing with aging such as HutchinsonGilford Progeria Syndrome.
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